Screening policies for cytomegalovirus in pregnancy in the era of antivirals

Monitoring (maternal blood tests, serum valaciclovir concentrations, fetal ultrasounds) was uneventful. [...]off-licence antiviral treatment with valganciclovir (900 mg twice daily) was initiated after discussions with the multidisciplinary team, for a total of 6 weeks in the acute phase of presumed fetal myocarditis. There is an urgent public health need to create a unified and equitable approach to screening, surveillance, and treatment, especially as some pregnant women are receiving inconsistent care across countries, following different policies.